Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population

Abstract Background Long non encoding RNA (lncRNA) plays a crucial role in breast cancer. However, the prognostic role of AFAP1‐AS1 in breast cancer remains unclear. Aims To investigate the relationship between the expression of long non‐coding RNA actin filament‐associated protein1 antisense RNA1 (...

Full description

Bibliographic Details
Main Authors: Zhenxing Yang, Tao Huang, Chong Sheng, Kaijuan Wang, Yilin Li, Yajing Feng, Dandan Huo, Fujiao Duan
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1923
_version_ 1827372929338310656
author Zhenxing Yang
Tao Huang
Chong Sheng
Kaijuan Wang
Yilin Li
Yajing Feng
Dandan Huo
Fujiao Duan
author_facet Zhenxing Yang
Tao Huang
Chong Sheng
Kaijuan Wang
Yilin Li
Yajing Feng
Dandan Huo
Fujiao Duan
author_sort Zhenxing Yang
collection DOAJ
description Abstract Background Long non encoding RNA (lncRNA) plays a crucial role in breast cancer. However, the prognostic role of AFAP1‐AS1 in breast cancer remains unclear. Aims To investigate the relationship between the expression of long non‐coding RNA actin filament‐associated protein1 antisense RNA1 (AFAP1‐AS1) and prognosis of breast cancer. Methods and Results Meta‐analysis was performed to explore the correlation between AFAP1‐AS1 and breast cancer. The AFAP1‐AS1expression in patients with breast cancer tissue and adjacent normal tissue from 153 patients was determined by qRT‐PCR. Bioinformatics and Cox proportional‐hazards risk model were used to explore the relationship between expression of AFAP1‐AS1 and prognosis. The combined analysis revealed a significant correlation between AFAP1‐AS1 expression and both overall survival (hazard ratios, HR = 2.33, 95%Cl: 1.94–2.81, p < 0.001) as well as disease‐free survival/progression‐free survival (HR = 2.94, 95%CI: 2.35–3.67, p < 0.001). The relation between expression of AFAP1‐AS1 and breast cancer was determined in 153 breast cancer and adjacent normal tissues. The findings revealed a significantly higher AFAP1‐AS1expression levels in breast cancer tissues compared to adjacent normal tissues (p < 0.001). Additionally, patients exhibiting heightened levels of AFAP1‐AS1 expression were correlated with an unfavorable prognosis (HR = 2.35, 95%CI: 1.47–3.74, p < 0.001), which aligns consistently with the findings of the pooled analysis. The subgroup analysis of clinical characteristics revealed a significant association between high expression of AFAP1‐AS1 and TNM stage (HR = 1.72, 95%CI: 1.11–2.65, p = 0.015). Conclusion This study demonstrated that AFAP1‐AS1 acts as an oncogene and may serve as a novel prognostic marker for breast cancer, particularly in the Chinese population.
first_indexed 2024-03-08T11:08:24Z
format Article
id doaj.art-5b2649376132439bb2bc129954ac8435
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-03-08T11:08:24Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-5b2649376132439bb2bc129954ac84352024-01-26T14:25:02ZengWileyCancer Reports2573-83482024-01-0171n/an/a10.1002/cnr2.1923Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese populationZhenxing Yang0Tao Huang1Chong Sheng2Kaijuan Wang3Yilin Li4Yajing Feng5Dandan Huo6Fujiao Duan7Department of Medical Research Office the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou ChinaDepartment of Medical Research Office the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou ChinaCollege of Public Health Zhengzhou University Zhengzhou ChinaCollege of Public Health Zhengzhou University Zhengzhou ChinaDepartment of Medical Research Office the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou ChinaDepartment of Hospital Infection Management the First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Medical Research Office the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou ChinaDepartment of Medical Research Office the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou ChinaAbstract Background Long non encoding RNA (lncRNA) plays a crucial role in breast cancer. However, the prognostic role of AFAP1‐AS1 in breast cancer remains unclear. Aims To investigate the relationship between the expression of long non‐coding RNA actin filament‐associated protein1 antisense RNA1 (AFAP1‐AS1) and prognosis of breast cancer. Methods and Results Meta‐analysis was performed to explore the correlation between AFAP1‐AS1 and breast cancer. The AFAP1‐AS1expression in patients with breast cancer tissue and adjacent normal tissue from 153 patients was determined by qRT‐PCR. Bioinformatics and Cox proportional‐hazards risk model were used to explore the relationship between expression of AFAP1‐AS1 and prognosis. The combined analysis revealed a significant correlation between AFAP1‐AS1 expression and both overall survival (hazard ratios, HR = 2.33, 95%Cl: 1.94–2.81, p < 0.001) as well as disease‐free survival/progression‐free survival (HR = 2.94, 95%CI: 2.35–3.67, p < 0.001). The relation between expression of AFAP1‐AS1 and breast cancer was determined in 153 breast cancer and adjacent normal tissues. The findings revealed a significantly higher AFAP1‐AS1expression levels in breast cancer tissues compared to adjacent normal tissues (p < 0.001). Additionally, patients exhibiting heightened levels of AFAP1‐AS1 expression were correlated with an unfavorable prognosis (HR = 2.35, 95%CI: 1.47–3.74, p < 0.001), which aligns consistently with the findings of the pooled analysis. The subgroup analysis of clinical characteristics revealed a significant association between high expression of AFAP1‐AS1 and TNM stage (HR = 1.72, 95%CI: 1.11–2.65, p = 0.015). Conclusion This study demonstrated that AFAP1‐AS1 acts as an oncogene and may serve as a novel prognostic marker for breast cancer, particularly in the Chinese population.https://doi.org/10.1002/cnr2.1923breast cancerlncRNA AFAP1‐AS1prognosissystem evaluation
spellingShingle Zhenxing Yang
Tao Huang
Chong Sheng
Kaijuan Wang
Yilin Li
Yajing Feng
Dandan Huo
Fujiao Duan
Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
Cancer Reports
breast cancer
lncRNA AFAP1‐AS1
prognosis
system evaluation
title Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
title_full Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
title_fullStr Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
title_full_unstemmed Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
title_short Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
title_sort prognostic value of lncrna afap1 as1 in breast cancer a meta analysis and validated study in chinese population
topic breast cancer
lncRNA AFAP1‐AS1
prognosis
system evaluation
url https://doi.org/10.1002/cnr2.1923
work_keys_str_mv AT zhenxingyang prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT taohuang prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT chongsheng prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT kaijuanwang prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT yilinli prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT yajingfeng prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT dandanhuo prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation
AT fujiaoduan prognosticvalueoflncrnaafap1as1inbreastcancerametaanalysisandvalidatedstudyinchinesepopulation